Possible reasons for why a new study could not replicate our finding that the serotonin reuptake inhibitor citalopram decreased amyloid concentrations in the cerebrospinal fluid of healthy volunteers. of escitalopram, the active in their Letter) will clarify the discrepancies in the results. These methodological differences relate with drug timing and dose of CSF sampling. Escitalopram… Continue reading Possible reasons for why a new study could not replicate our